Page last updated: 2024-09-02

fingolimod hydrochloride and Angiogenesis, Pathologic

fingolimod hydrochloride has been researched along with Angiogenesis, Pathologic in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (46.15)	29.6817
2010's	6 (46.15)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Aoki, M; Honda, A; Kondo, A; Matsunaga, N; Ogawa, R; Okubo, Y; Takabe, K	1
Cho, H; Du, G; Du, X; Fang, J; Fang, Q; Lee, LP; Li, W; Yu, M	1
Bao, X; Chen, W; Wang, L; Xie, F; Xu, Q; Yu, J; Zhang, Z	1
Ader, I; Cuvillier, O; Gstalder, C	1
Hla, T; Obinata, H	1
Fan, ST; Geng, W; Li, CX; Ling, CC; Liu, XB; Lo, CM; Ma, YY; Man, K; Ng, KT; Shao, Y	1
Cao, F; Fan, L; Gao, H; Tao, L; Wang, H; Wei, L; Yin, Z; Zhang, R	1
Chan, FL; Chua, CW; Ho, J; Lee, DT; Ling, MT; Man, K; Wang, X; Wong, YC; Zhou, C	1
Fan, ST; Ho, JW; Lee, TK; Man, K; Poon, RT; Sun, CK	1
Chu, AC; Fan, ST; Ho, JW; Lee, TK; Man, K; Ng, IO; Ng, KT; Poon, RT; Sun, CK; Sun, HC; Tang, ZY; Wang, XH; Xu, R; Xu, Y	1
Billy, E; Butler, J; Hla, T; LaMontagne, K; Liau, G; Littlewood-Evans, A; O'Reilly, T; Probst, B; Sanchez, T; Schnell, C; Theuer, A; Wood, A; Wood, J; Wyder, L	1
Huwiler, A; Pfeilschifter, J	1
Bruns, CJ; Graeb, C; Guba, M; Heeschen, C; Ischenko, I; Jauch, KW; Joka, M; Papyan, A; Schmid, G; Schrepfer, S	1

Reviews

1 review(s) available for fingolimod hydrochloride and Angiogenesis, Pathologic

Article	Year
Sphingosine 1-phosphate in coagulation and inflammation. Seminars in immunopathology, 2012, Volume: 34, Issue:1 Topics: Animals; Atherosclerosis; Blood Coagulation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Inflammation; Lymph Nodes; Lymphocytes; Lysophospholipids; Multiple Sclerosis; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Tumor Necrosis Factor-alpha	2012

Article

Year

Sphingosine 1-phosphate in coagulation and inflammation.

Seminars in immunopathology, 2012, Volume: 34, Issue:1

Topics: Animals; Atherosclerosis; Blood Coagulation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Inflammation; Lymph Nodes; Lymphocytes; Lysophospholipids; Multiple Sclerosis; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Tumor Necrosis Factor-alpha

2012

Other Studies

12 other study(ies) available for fingolimod hydrochloride and Angiogenesis, Pathologic

Article	Year
The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars. Journal of immunology research, 2020, Volume: 2020 Topics: Animals; Cell Differentiation; Cicatrix, Hypertrophic; Cytokines; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lysophospholipids; Macrophages; Mechanical Phenomena; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; RAW 264.7 Cells; Sphingosine; Th1-Th2 Balance; Th2 Cells	2020
Droplet Array-Based 3D Coculture System for High-Throughput Tumor Angiogenesis Assay. Analytical chemistry, 2018, 03-06, Volume: 90, Issue:5 Topics: Angiogenesis Inhibitors; Animals; Cell Communication; Cell Line, Tumor; Coculture Techniques; Drug Screening Assays, Antitumor; Endothelial Cells; Fingolimod Hydrochloride; High-Throughput Screening Assays; Human Umbilical Vein Endothelial Cells; Humans; Microfluidics; Neovascularization, Pathologic; Rats	2018
Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK. Oncotarget, 2015, Sep-22, Volume: 6, Issue:28 Topics: Animals; Antigens, Polyomavirus Transforming; Antineoplastic Agents; Cell Line; Cell Movement; Cell Proliferation; Endothelial Cells; Enzyme Activation; Enzyme Activators; Extracellular Signal-Regulated MAP Kinases; Fingolimod Hydrochloride; Hemangioma; Humans; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Neoplasms, Experimental; Neovascularization, Pathologic; Phosphorylation; Protein Multimerization; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; RNA Interference; Signal Transduction; Transfection	2015
FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model. Molecular cancer therapeutics, 2016, Volume: 15, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Fingolimod Hydrochloride; Gene Expression; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lysophospholipids; Mice; Neovascularization, Pathologic; Oxygen Consumption; Phosphotransferases (Alcohol Group Acceptor); Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Vascular Endothelial Growth Factor A; Vascular Remodeling; Xenograft Model Antitumor Assays	2016
FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells. PloS one, 2012, Volume: 7, Issue:2 Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Fingolimod Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Immunosuppressive Agents; Liver; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Propylene Glycols; Rats; Reperfusion Injury; Sphingosine; Stem Cells; Time Factors	2012
FTY720 protects cardiac microvessels of diabetes: a critical role of S1P1/3 in diabetic heart disease. PloS one, 2012, Volume: 7, Issue:8 Topics: Apoptosis; Base Sequence; Blotting, Western; Coronary Vessels; Diabetes Complications; DNA Primers; Fingolimod Hydrochloride; Heart Diseases; Humans; In Situ Nick-End Labeling; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microvessels; Neovascularization, Pathologic; Propylene Glycols; Receptors, Lysosphingolipid; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine	2012
FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer. International journal of cancer, 2005, Dec-20, Volume: 117, Issue:6 Topics: Androgens; Animals; Apoptosis; beta Catenin; Body Weight; Cadherins; Caspase 3; Caspases; Cell Division; Fingolimod Hydrochloride; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Orchiectomy; Platelet Endothelial Cell Adhesion Molecule-1; Propylene Glycols; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sphingosine; Vascular Endothelial Growth Factor A	2005
Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma. Molecular cancer therapeutics, 2005, Volume: 4, Issue:9 Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Endothelium, Vascular; Fingolimod Hydrochloride; Flow Cytometry; G1 Phase; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microcirculation; Neovascularization, Pathologic; Propylene Glycols; Sphingosine; Transplantation, Heterologous; Umbilical Veins; Wounds and Injuries	2005
FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Dec-01, Volume: 11, Issue:23 Topics: Animals; Antigens, CD34; Carcinoma, Hepatocellular; Disease Models, Animal; Down-Regulation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Liver Neoplasms, Experimental; Mice; Mice, Nude; Microcirculation; Neovascularization, Pathologic; Propylene Glycols; rac GTP-Binding Proteins; Sphingosine; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Wound Healing	2005
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer research, 2006, Jan-01, Volume: 66, Issue:1 Topics: Animals; Calcium; Cell Growth Processes; Cell Movement; Cornea; Endothelial Cells; Female; Fingolimod Hydrochloride; Humans; Melanoma, Experimental; Mice; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Phthalazines; Propylene Glycols; Pyridines; Receptors, Lysosphingolipid; Sphingosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2006
Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. Current pharmaceutical design, 2006, Volume: 12, Issue:35 Topics: Amidohydrolases; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Ceramidases; Ceramides; Enzyme Inhibitors; Fingolimod Hydrochloride; Humans; Lipid Metabolism; Lysophospholipids; Neoplasms; Neovascularization, Pathologic; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine	2006
The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. Journal of cellular biochemistry, 2007, May-01, Volume: 101, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Cell Division; Cells, Cultured; Coculture Techniques; Collagen; Drug Combinations; Endothelium, Vascular; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Laminin; Mice; Mice, Inbred C57BL; Muscle, Smooth; Neoplasm Transplantation; Neovascularization, Pathologic; Neutralization Tests; Oxadiazoles; Propylene Glycols; Proteoglycans; Receptors, CXCR4; Receptors, Lysosphingolipid; Sphingosine; Thiophenes; Transcriptional Activation; Transplantation, Isogeneic; Umbilical Veins; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2007